Clinical Trials Sponsored by Calosyn Pharma, Inc.
Total 2368 results
-
Astellas Pharma IncAstellas Pharma Korea, Inc.CompletedOver Active BladderKorea, Republic of
-
Astellas Pharma IncAstellas Pharma Canada, Inc.Completed
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedHealthy Volunteer | Pharmacokinetics of YM178Taiwan
-
Astellas Pharma Korea, Inc.CompletedKidney TransplantationKorea, Republic of
-
Astellas Pharma IncAstellas Pharma Canada, Inc.Completed
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Astellas Pharma IncAstellas Pharma China, Inc.CompletedOveractive BladderChina
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedLiver Transplantation | Transplantation Immunology | Host vs Graft ReactionTaiwan
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedPsoriasisUnited States, Canada
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedCerebrovascular AccidentCanada, Belgium, United States, Germany, South Africa, Austria
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedAcute Ischemic StrokeCanada, United States, Germany, Belgium, Austria
-
Vifor Pharma, Inc.TerminatedHyperkalemiaUnited States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
-
Astellas Pharma IncAdvanz PharmaCompletedAtrial Fibrillation | Atrial FlutterUnited States, Argentina, Canada, Chile, Denmark, Mexico, Sweden
-
Astellas Pharma China, Inc.Seagen Inc.Active, not recruitingMetastatic Urothelial CancerChina
-
Vifor Pharma, Inc.RecruitingHyperkalemiaUnited States, Israel
-
Astellas Pharma IncAdvanz PharmaCompletedAtrial FibrillationUnited States, South Africa, Canada, Argentina, Denmark, Sweden
-
Astellas Pharma Korea, Inc.Seagen Inc.RecruitingUrothelial CancerKorea, Republic of
-
Carolyn BrittenOncovir, Inc.Completed
-
Astellas Pharma Global Development, Inc.RecruitingB-cell LymphomaAustralia
-
Astellas Pharma Global Development, Inc.Recruiting
-
Astellas Pharma Global Development, Inc.Recruiting
-
Astellas Pharma Global Development, Inc.Active, not recruitingAllergic to House Dust MitesGermany
-
Astellas Pharma Global Development, Inc.Active, not recruitingLeukemia, Acute Myeloid (AML)Japan, United States, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Taiwan, Turkey, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedChronic Kidney DiseaseGermany
-
Astellas Pharma Global Development, Inc.Active, not recruiting
-
Astellas Pharma Global Development, Inc.CompletedVasomotor SymptomsPoland, Spain, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Sweden, Turkey, United Kingdom
-
Astellas Pharma Global Development, Inc.TerminatedChronic Tympanic Membrane PerforationUnited States
-
Astellas Pharma Global Development, Inc.TerminatedPharmacokinetics of Mirabegron | Overactive Bladder (OAB)Korea, Republic of, Russian Federation, Turkey
-
Astellas Pharma Global Development, Inc.CompletedOvarian Cancer | NSCLC | Solid Tumors | ESCCUnited States
-
Astellas Pharma Global Development, Inc.CompletedRenal Impaired | Gilteritinib | Normal Renal Function | Pharmacokinetics of ASP2215United States, Bulgaria
-
Astellas Pharma Global Development, Inc.CompletedHealthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.TerminatedHealthy ParticipantsUnited States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Metastatic Hormone-sensitive Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Withdrawn
-
Astellas Pharma Global Development, Inc.CompletedHealthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia | Advanced Solid TumorsUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedHealthy SubjectsUnited States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaUnited States, Canada
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid Tumors | Pharmacokinetics of 14C-labeled GilteritinibUnited States
-
Astellas Pharma Global Development, Inc.Terminated
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Astellas Pharma Global Development, Inc.WithdrawnSolid Tumors | Epidermal Growth Factor Receptor (EGFR) Mutations
-
Astellas Pharma Global Development, Inc.CompletedCoronary Artery Disease (CAD)United States, Peru, Argentina, Puerto Rico
-
Astellas Pharma Global Development, Inc.TerminatedCandidiasisPhilippines, United States, Canada, Israel, Romania, Greece, Turkey, Brazil, Bulgaria, Colombia, Hungary, Ukraine
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP015K | Food EffectUnited States
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid Arthritis | Pharmacokinetics of ASP2409United States